euronanomed.net

  • Increase font size
  • Default font size
  • Decrease font size

GUIDELINES

DOWNLOAD THE PDF DOCUMENT

Back to Calls


EuroNanoMed 2nd Joint Transnational Call for Proposals (2010) for

 

“European Innovative Research & Technological Development Projects in Nanomedicine”

 

March 8th 2010
 

Guidelines for Applicants 

Background

Under the umbrella of EuroNanoMed (ERA-Net for research programmes on Nanomedicine), 16 funding organisations have agreed to launch the 2nd Joint Transnational Call (JTC) in 2010 for collaborative research projects in Nanomedicine. The EuroNanoMed funding organisations particularly wish to promote innovative interdisciplinary collaboration and to encourage translational research proposals.

Registration

Research project consortia who intend to submit a transnational proposal should register as soon as possible at http://www.euronanomed.net, clicking the “to register” button and following the directions. The system will be opened in March 8th 2010. To register, please fill in the data sheet of the system. The same data sheet can later be used for the final electronic proposal submission.

Proposal submission

Please read carefully the relevant central and member states/regional eligibility and budgetary criteria before starting your proposal in order to check if you fulfil the call’s formal requirements.

 
Only transnational projects will be funded. Each proposal must involve a minimum of three research groups from three different countries including at least two EuroNanoMed member states participating as funders in the 2nd joint transnational call and a maximum of seven project partners. The majority of research groups in a consortium and the coordinator must be from EuroNanoMed funding member states.
 
Electronic proposal submission is mandatory. For application please use the proposal template provided on the EuroNanoMed web page (http://www.euronanomed.net/index.php/contacts). Please fill in all fields and submit online your proposal in a digitally signed PDF-Format file fully uploading it before June 11th 2010 at 17:00:00 (CET Brussels local time). After this time, the server will not accept proposals. Please take into account that the online data entry may be overloaded by the day of the deadline. It is therefore recommended to upload all mandatory data in proper time.
For applicants from some member states/regions it might be also necessary to submit the proposal and/or other information directly to the relevant national/regional funding organizations. Therefore, applicants are strongly advised to check their respective member states/region funding organization eligibility and other specific information. For more details, applicants may also get in touch with the respective funding organizations Contact Persons. For central and additional information you can contact:
EuroNanoMed Joint Call Secretariat (JCS)
Veneto Nanotech s.c.p.a.
Via San Crispino, 106
35129 Padova – Italy 
 
Phone: +39 049 7705520
Fax: +39 049 7705555
 
Opening hours:
Monday to Thursday 9.00-13.00 and 14.30-18.00
Friday 9.00-13.00 and 14.30-17.00 (Brussels local time)
 

Proposal structure

One joint proposal document (in English) shall be prepared by the partners of a joint transnational proposal, which must be submitted to the Joint Call Secretariat (JCS) by the transnational project consortium coordinator.
Please keep in mind that the template has a fixed maximum size. Thus, the proposal document cannot be longer than the number of pages indicated below (DIN-A4, Arial 11, single-spaced). Proposals exceeding these limitations will be rejected.
Proposals must include the following information:
  • Family names, first names and full affiliations (by this order) of the project coordinator.
  • Family names, first names and full affiliations (by this order) of each partner principal investigators (one per project partner) and other team members participating in the project.
  • Duration of project
  • Total project cost and budget to be publically funded by the EuroNanoMed funding organizations.
  • Clinical/public health application (yes or no), industrial/SME application (yes or no):
1.    Diagnostics (yes or no),
2.    Targeted drug delivery (yes or no),
3.    Regenerative medicine (yes or no)
  • Scientific abstract(max. ½ page)
  • Keywords (5 to 7)
  • Background and present state of the art in the research field (max. 2 pages)
  • Timely work plan (aims, methodology, involvement of project partner team members, project coordination and management; max. 8 pages)
  • Financial summary for each project consortium partner provided on the respective table available within the electronic application data sheet.
  • Justifications of requested and total project cost (e.g. own contribution + other sources + requested). When applicable specifying co-funding from other sources necessary for the project (max. 1 page)
  • Added value of the proposed international collaboration (max. 1 page)
  • Potential impact and exploitation of expected project results (max. 1 page)
  • Present and anticipated future position with regard to IPR (e.g. any barriers to sharing materials or results), both within and outside the consortium, if applicable (max. ½ page)
  • Description of ongoing projects, pending patents and patents when applicable of each participating project partner related to the present topic indicating funding sources and possible overlaps with proposal (max. 1 page per group)
  • Ethical issues of the project proposal. When applicable, ethical and legal issues (e.g. informed consent, ethical permits, data protection, use of animals) according to national regulations (max. ½ page)
  • Brief CVs for each participating project partner Principal Investigator with a list of up to five relevant publications within the last five years demonstrating the competence to carry out the project (max. 1 page each)
  • When requested by national/regional EuroNanoMed funding bodies, additional information must be provided to them.
  • Project partners from EuroNanoMed member states/regions not participating in this 2nd call and non-EuroNanoMed member states may participate in projects if they are able to secure their own funding before the recommendation of funding is taken by EuroNanoMed Call Steering Committee (CSC). A signed statement has to be enclosed declaring in advance they will run the project with their own resources.
  • Signatures of all project partners principal investigators (signed PDF) declaring they keep records with evidence that each of their respective team members agreed to participate in the proposal submitted.  

Please note that after submission of the proposal once the joint transnational call has been closed it is not possible to amend the proposal or to add further documents.

Applicants may ask not to refer their applications to certain reviewers, giving a reasonable ground for this. EuroNanoMed may consider meeting this request but it is not obliged to do it.

Please note

It is mandatory to meet the deadline and observe the format of the proposal structure.

The Joint Call Secretariat will assess proposals to ensure that they meet the call’s formal criteria (e.g. date of submission; number of participating member states, type of project partners (academic, clinical/public health and industrial/SMEs), and inclusion of all necessary information in English). In parallel, the Joint Call Secretariat will forward the proposals to the relevant EuroNanoMed member state/regional funding organisations that will perform a formal check of compliance with their respective eligibility criteria. Proposals not meeting the formal central and /or member state/regional eligibility criteria will be rejected. Proposals passing both checks will be forwarded to independent international scientific experts for evaluation.
Potential project consortium coordinators are recommended to read the EuroNanoMed funding organizations’ eligibility when they are looking for potential project consortium partners.
Project partners are strongly advised to read the specific eligibility criteria of the relevant EuroNanoMed funding organizations and other requirements and to contact their respective Contact Persons prior to submitting the application (see "Information for Applicants" or see "Contact Point list", http://www.euronanomed.net/).